Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If You Thought Covid Was Over…Congratulations, You’re an Idiot:
https://eand.co/if-you-thought-covid-was-over-congratulations-youre-an-idiot-3ee89501df92
When a disease becomes "endemic," it may still cause suffering and death -- as malaria and tuberculosis do, for example.
I agree 1000%
-Full on pandemic in its 3 rd year-
keeps changing
it is still early " covid endemic"
When a disease becomes "endemic," it may still cause suffering and death -- as malaria and tuberculosis do, for example. @DrMikeRyan explains that even if #COVID19 becomes endemic, it will remain important to reduce infections, suffering and death. pic.twitter.com/ds5FFRhvO0
— World Health Organization (WHO) (@WHO) March 12, 2022
$MRNA MULTIDOLLAR$$$$$ running....
countdown!!!!! 6 days to go! We will be hosting our third annual virtual Vaccines Day for analysts and investors at 8:00 a.m. ET on Thursday, March 24. Sign up here:
https://moderna-vaccines-day-2022.open-exchange.net/registration
$MRNA WINNER$
it's you, the slave!
LOL you're back,I am happy!!!!!!!
Covid will come back. This will zoom past......"sure as death"
Still waiting for anyone to find me another company on this planet with more revenue per employee than moderna$$$$$$$$
We have submitted a request to the U.S. FDA for an amendment to the emergency use authorization to allow for a fourth dose of our COVID19 vaccine in adults 18 years of age and older who have received an initial booster of any of the authorized or approved COVID-19 vaccines.
https://investors.modernatx.com/news/news-details/2022/Moderna-Submits-Amendment-to-the-Emergency-Use-Authorization-for-an-Additional-Booster-Dose-of-its-COVID-19-Vaccine-in-the-U.S/default.aspx
r.i.p
CHILDREN (6-11 YEARS) This announcement follows the recent authorization of our COVID-19 vaccine in the same age group in both Australia and the European Union.
mRNA-1273 COVID-19 vaccine Spontaneous tumor regression following COVID-19 vaccination.
https://jitc.bmj.com/content/10/3/e004371
this is the future RNA
time will tell $$$$$$$$$
"Health Canada was the first regulator to fully approve our COVID-19 vaccine, and we are pleased they have taken this important step to expand this authorization to children aged 6 to11 years,"
HEALTH CANADA AUTHORIZES MODERNA'S COVID-19 VACCINE IN CHILDREN (6-11 YEARS)
https://investors.modernatx.com/news/news-details/2022/Health-Canada-Authorizes-Modernas-COVID-19-Vaccine-in-Children-6-11-Years/default.aspx
Analyst Leah R. Cann from Brookline Capital Markets reiterated a Buy rating on Moderna (MRNA), with a $506 price target.
cancer vaccine phase 2 results update slated for Q2 2022 (April-June)
next year they will have CMV and RSV vaccines on the market and a Zika vaccine hitting end stage 3 trials!
Covid is a catalyst to enable MRNA to become a revolutionary and prolific company!
Highly undervalued$$$$$$$$$
Analyst Salveen Richter from Goldman Sachs reiterated a Buy rating on Moderna (MRNA), with a $397 price target.
Oppenheimer 32nd Annual Healthcare Conference on Thursday, March 17th at 10:00 a.m. ET
https://wsw.com/webcast/oppenheimer20/register.aspx?conf=oppenheimer20&page=mrna&url=https://wsw.com/webcast/oppenheimer20/mrna/2771748
Moderna opened an office in HK, Singapore so as to serve ASIA !
ORDERS WILL COME$$$$$$$$$$
" China should buy from Moderna and Pfizer. If that happens, it's going to be a hell of party "
9 days to go! We will be hosting our third annual virtual Vaccines Day for analysts and investors at 8:00 a.m. ET on Thursday, March 24. Sign up here:
https://moderna-vaccines-day-2022.open-exchange.net/registration
9 days to go!📅 We will be hosting our third annual virtual Vaccines Day for analysts and investors at 8:00 a.m. ET on Thursday, March 24. Sign up here: https://t.co/sOlhiIccrL pic.twitter.com/lBTsvQ5QP6
— Moderna (@moderna_tx) March 15, 2022
List of short to mid term SP catalysts:
1. FDA submission seeking label expansion to 6m to 5 yr olds (expected within days, anytime now)
2. Flu vaccine pH2 result (Depending on data processing, there is a chance that this will be released on mrna vaccine day (24rd this month). Even if not out then, it will be in short number of weeks after)
3. Omicron vaccine pH1 (preliminary result in the next month or two, rolling submission to the fda (early summer))
Source: Barclays conference, paraphasing Dr. Paul Burton's (CMO) statement.
Do your own DD and trust no one.
MODERNA AND THE JAPANESE GOVERNMENT REACH AN AGREEMENT TO SUPPLY JAPAN WITH ADDITIONAL 70 MILLION DOSES OF MODERNA'S COVID-19 BOOSTER VACCINE
https://investors.modernatx.com/news/news-details/2022/Moderna-and-the-Japanese-Government-Reach-an-Agreement-to-Supply-Japan-with-Additional-70-Million-Doses-of-Modernas-COVID-19-Booster-Vaccine/default.aspx
China at a COVID Tipping Point:
https://medriva.com/china-at-a-covid-tipping-point/#gs.tvwt0r
Tune in at 1:30 pm this afternoon to hear the latest from our CMO Paul Burton at 2022 Conference.
https://investors.modernatx.com/Events--Presentations/events-and-presentations/event-details/2022/Barclays-Global-Healthcare-Conference/default.aspx
is are the beginning of the research, perhaps we have found the cure for cancer!
That's incredible!
Spontaneous tumor regression following COVID-19 vaccination "vaccine moderna"
https://jitc.bmj.com/content/10/3/e004371
Moderna Announces First Participant Dosed in Phase 1 Study of its HIV Trimer mRNA Vaccine:
https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-First-Participant-Dosed-in-Phase-1-Study-of-its-HIV-Trimer-mRNA-Vaccine/default.aspx
Coronavirus: Swiss federal government secures supply of vaccines for 2023
the Federal Council has decided to also procure seven million doses from Moderna.
https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-87570.html
Moderna plans to offer omicron vaccine as early as autumn in Japan:
Rami Suzuki, president of Moderna Japan Inc., the Japanese arm of the U.S. pharmaceutical giant, told reporters that the company is conferring with Japan's health ministry on a domestic rollout as early as this autumn.
this may be the first glimpse of possible government level pre-order for the omicron customized mrna vaccine$$$$$$$$
https://mainichi.jp/english/articles/20220312/p2a/00m/0na/002000c
HI buy insider slrx: $ 0.391 2022-03-09
https://www.secform4.com/filings/1615219/0001615219-22-000019.htm
https://www.secform4.com/filings/1615219/0001615219-22-000018.htm
H.C. Wainwright analyst Michael King reiterated a Buy rating on Salarius Pharmaceuticals (SLRX – Research Report) today and set a price target of $4.00.
UQ partners with Moderna to use mRNA technology to research global public health threats:
https://www.uq.edu.au/news/node/131499
Could Moderna's Next Step Be Worth Billions:
Moderna is preparing for what the World Health Organization calls "Disease X."
https://www.fool.com/investing/2022/03/10/could-modernas-next-step-be-worth-billions/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article
Analyst Edward Tenthoff from Piper Sandler maintained a Buy rating on Moderna (MRNA), with a $348 price target.